Risk of cancer-specific mortality following recurrence after radical nephroureterectomy Academic Article uri icon

Overview

MeSH Major

  • Lymph Node Excision
  • Neoplasm Recurrence, Local
  • Nephrectomy
  • Ureteral Neoplasms

abstract

  • Approximately 80 % of patients who experience disease recurrence after RNU die within 2 years after recurrence. Patients with non-organ-confined stage, absence of lymph node dissection, ureteral tumor location and/or shorter time to disease recurrence died of their tumor more quickly than their counterparts. These factors should be considered in patient counseling and risk stratification for salvage treatment decision making.

publication date

  • December 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3576920

Digital Object Identifier (DOI)

  • 10.1245/s10434-012-2499-8

PubMed ID

  • 22805867

Additional Document Info

start page

  • 4337

end page

  • 44

volume

  • 19

number

  • 13